Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases

Proton pump inhibitors (PPIs) have been associated with decreased gut microbiota diversity. Disrupted gut microbiota composition has been reported in several autoimmune diseases (ADs), such as type 1 diabetes mellitus (DM), autoimmune thyroiditis (AIT), juvenile idiopathic arthritis (JIA), and infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Räisänen, Laura, Viljakainen, Heli, Kolho, Kaija-Leena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083351/
https://www.ncbi.nlm.nih.gov/pubmed/37051434
http://dx.doi.org/10.3389/fped.2023.1157547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083351/
https://www.ncbi.nlm.nih.gov/pubmed/37051434
http://dx.doi.org/10.3389/fped.2023.1157547

Ejemplares similares